Australia's Iress falls; Morningstar says shares undervalued

By Reuters News

** Shares of Australian fintech company Iress IRE.AX drop as much as 2.4% to A$5.64, their lowest since November 4

** Analysts at Morningstar maintain their fair value estimate at A$7 a share, saying shares are undervalued, with its low trade price implying faster customer losses than forecasted
** Investment research firm describes the company to have a narrow-moat, driven by Xplan, Iress's financial advice and wealth management software

** "We think they keep Xplan level with rivals and give advisers less reason to leave... they do not put Iress ahead, though," Morningstar adds

** Xplan is still in a prototype stage, with parts due in the coming two years

** Six of seven analysts rate the stock "buy" or higher, one "hold"; their median PT is A$9.37 – LSEG-compiled data

** Iress down 33.5% YTD

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.